the company has been surprisingly quiet. Will they speak prior to reporting end of quarter? Still no word on new signings [ HEALTH SITE ], not very promising IMO. Seems like stock is stuck in trading range till news. Any opinions
10k shares 12/31/14 for $1.2294 and the next trading day volume jumps from 60k share av. to 743k and pps jumps 34% on no news..................not much money but very odd.........................
Valid concern but last years news. IMO he was not on top of things to the boards satisfaction and they let him resign to save face. He should have seen , advised and revised the timeline for approvals better, once again just my opinion. The device works well in trials and should continue on path to approval in 2015. A lot of smart money is involved.
Jane Hsiao sits on TRXC board and is stockholder. Among her many positions she is Vice Chairman of OPKO , and many consider her Dr. Frosts right hand. Do some DD, she is an impressive lady IMO.
average volume 139k, today 1.4 million @ 1pm and no news showing presently. Have been accumulating on the way down since $2.10 range and not complaining, the insane spike in volume with no catalyst is puzzling. Anyone heard anything?
IMO , OPKO is Dr. Frost's legacy.
The man has nothing further to prove about his Medical and financial abilities. His success's are documented. I believe he has/is creating a company to impress himself and benefit patients and investors alike. A worldwide concern that will rival the largest and best .He will not sell but will continue to buy promising startups,merge, aquire and do everything that he has been doing to reach that end. He has nobody left to impress but himself and I for one have been and will continue to go along for the ride as long as he is involved.
The hard Technical bottom of $1.80ish is at hand. Weak hands have been flushed and volume is holding. On the Fundamental side if the company now address's the COO problem correctly and can assure investors the latest hiccup regarding device timeline is under control we might see a return to the $2.50-$3 range quickly. When fundamentals and technicals are in union things happen quickly one way or the other, time to buckle up IMO.
Now regarding the big heavy guy in the red suit.................................................
ffighter answered your question from the technical side, rather nicely, since technicians represent a heavy % of traders do not dismiss his reasoning/explanation so quickly. As a person who follows fundamentals, the COO resigning [?] and leaving without notice equals red flag and the company and EX COO not talking or explaining? Did you think to ask during your conversation what the $%^&&^% that was all about? One would think it odd for a COO to leave at such a time, with a big payday so close, no. The fact that the device is being delayed isn't ringing any bells?
This is a highly speculative stock that just rocked the investors last quarter and your question is?
If/when the device gets ins. coding and ins. reimbursement and if the device were to be scaled for consumer use as well as Derm/institutional use, ie a scaled down version of device, sold to consumers for personal use/ reference on HSN. What do you think the market potential would be?
Just a thought...........................
Where are you getting info on short positions? I can't find info on NASDAQ, YAHOO, etc......IMO the problem is that the CEO thru out a 2.5 million number with a timeline and now is tied to it. The company is fine and is tracking very well, management needs to be more careful with projecting numbers and timelines.